Home
About
Overview
Sharing Data
ORCID
Help
History (8)
Nivolumab-induced hepatitis: A rare side effect of an immune check point inhibitor.
Transplantation in miniature swine. IX. Swine histocompatibility antigens: isolation and purification of papain-solubilized SLA antigens.
Assessment of clinician accuracy for diagnosing melanoma on the basis of electrical impedance spectroscopy score plus morphology versus lesion morphology alone.
Novel organization of genes in a phthalate degradation operon of Mycobacterium vanbaalenii PYR-1.
Potential role of rituximab in metastatic castrate-resistant prostate cancer.
See All 8 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Potential role of rituximab in metastatic castrate-resistant prostate cancer.
Bindal P, Jalil SA, Holle LM, Clement JM. Potential role of rituximab in metastatic castrate-resistant prostate cancer. J Oncol Pharm Pract. 2019 Sep; 25(6):1509-1511.
View in:
PubMed
subject areas
Aged
Androgen Antagonists
Antineoplastic Agents, Immunological
Humans
Male
Prostatic Neoplasms, Castration-Resistant
Rituximab
authors with profiles
Poorva Bindal MD